Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tonglin guben 1 hao fang
- Development stage
- Unknown
- Lead developer
- Shenzhen Traditional Chinese Medicine Hospital
- Administration
- Oral
01
Overview
Tonglin Guben No. 1 Fang is a Traditional Chinese Medicine (TCM) herbal formula primarily developed and utilized in China for the treatment of chronic prostatitis and recurrent urinary tract infections. It is designed based on the TCM principles of clearing heat and promoting diuresis (Tonglin) while strengthening the vital essence and consolidating the foundation (Guben). The formula typically targets patients presenting with a pattern of spleen and kidney deficiency combined with damp-heat stasis. Clinical and pharmacological studies, often conducted at institutions like the Shenzhen Traditional Chinese Medicine Hospital, have demonstrated its efficacy in improving clinical symptoms such as urinary frequency, urgency, and pelvic pain. Research indicates that the formula exerts anti-inflammatory effects by downregulating the expression of pro-inflammatory cytokines, including interleukin-1 beta (IL-1β) and tumor necrosis factor (TNF), within the prostatic microenvironment.
- Other names
- 通淋固本1号方Tonglin Guben No. 1 FangTonglin Guben 1 Hao FangTonglin Guben No. 1 Formula
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on tonglin guben 1 hao fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tonglin guben 1 hao fang.